marbofloxacin has been researched along with Experimental Lung Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batmaz, H; Kacar, Y; Mecitoglu, Z; Yilmaz, OE | 1 |
| Dorey, L; Hobson, S; Lees, P | 1 |
2 other study(ies) available for marbofloxacin and Experimental Lung Inflammation
| Article | Year |
|---|---|
Comparing clinical effects of marbofloxacin and gamithromycin in goat kids with pneumonia.
Topics: Animals; Anti-Bacterial Agents; Disease Outbreaks; Fluoroquinolones; Goat Diseases; Goats; Macrolides; Mycoplasma; Pneumonia; Random Allocation; Respiratory Sounds; Treatment Outcome | 2018 |
Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida; Pneumonia; Swine; Swine Diseases | 2017 |